Merck Serono S.A. v The Comptroller-General of Patents, Designs and Trade Marks

Core Citations

CONSIDERS

• European Union (Withdrawal) Act 2018 - Articles : S-6
• The Patents (Amendment) (EU Exit) Regulations 2019

CONSIDERS

• Neurim Pharmaceuticals (1991) Ltd v The Comptroller-General of Patents

REFERS TO

• Abraxis Bioscience LLC v The Comptroller-General of Patents
• Actavis UK Ltd and Others v Eli Lilly and Company
• Henderson (a protected party by her Litigation Friend the Official Solicitor) v Dorset Healthcare University NHS Foundation Trust

[See more]

• Peninsula Securities Ltd v Dunnes Stores (Bangor) Ltd

CITES

• Neurim Pharmaceuticals (1991) Ltd v The Comptroller-General of Patents

This document cites

• Actavis UK Ltd and Others v Eli Lilly and Company
• Abraxis Bioscience LLC v The Comptroller-General of Patents
• Neurim Pharmaceuticals (1991) Ltd v The Comptroller-General of Patents
• European Union (Withdrawal) Act 2018
• The Patents (Amendment) (EU Exit) Regulations 2019



See all quotations

• Council Regulation (EEC) No 1768/92 of 18 June 1992 concerning the creation of a supplementary protection certificate for medicinal products
• Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal products for human use
• Regulation (EC) No 469/2009 of the European Parliament and of the Council of 6 May 2009 concerning the supplementary protection certificate for medicinal products (Codified version) (Text with EEA relevance)
• Directive 2001/82/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to veterinary medicinal products
• Axogen Corporation v Aviv Scientific Ltd
• Peninsula Securities Ltd v Dunnes Stores (Bangor) Ltd
• Henderson (a protected party by her Litigation Friend the Official Solicitor) v Dorset Healthcare University NHS Foundation Trust